Back to mobile site

JPMorgan Reiterates Neutral Rating on Emerson (EMR)

November 5, 2024 8:23 AM EST Send to a Friend
JPMorgan analyst C. Stephen Tusa Jr. reiterated a Neutral rating and $135.00 price target on Emerson (NYSE: EMR).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login